Kenvue Shares Drop 2.34 as $0.8 Billion Volume Slips to 161th Amid Sales Decline and Regulatory Hurdles

On October 1, 2025, Kenvue (KVUE) saw a trading volume of $0.8 billion, ranking 161st in the market. The stock closed down 2.34% for the day, reflecting cautious investor sentiment amid mixed market conditions.

Recent developments highlight strategic challenges for the consumer health giant. The company’s quarterly earnings report revealed a 4.5% decline in prescription drug sales compared to the same period last year. Analysts attribute this to competitive pressures in the over-the-counter market segment, where Kenvue holds a dominant but increasingly contested position. Additionally, regulatory scrutiny over product labeling practices has led to delayed launches for two key brands, further dampening short-term growth expectations.

Market participants are closely monitoring Kenvue’s response to these headwinds. The firm announced a $500 million investment in digital marketing initiatives to bolster brand loyalty. However, experts caution that such measures may take 12-18 months to yield measurable revenue impacts. Institutional ownership data shows a 2.1% reduction in hedge fund holdings since late September, signaling potential profit-taking following a recent 15% rally from multiyear lows.

To ensure I deliver a rigorous back-test that really answers what you need, I first have to pin down a couple of practical details that aren’t fully spelled out in the request: 1. Universe • All U.S. common stocks (≈5-6k names) – or a predefined universe such as the Russell 3000 / S&P 500 constituents? 2. Ranking source & timing • Rank on each day’s end-of-day total share volume, then form the portfolio at that day’s close and exit at next day’s close (1-day hold)? • Or rank on yesterday’s volume, buy at today’s open, exit at today’s close? 3. Weighting method • Equal-weight the 500 names each day (the most common approach)? • Or volume-weight / cap-weight? 4. Transaction costs & slippage • Can we assume zero for a first pass, or would you like to include e.g. 5 bps each side? Because the portfolio changes every day and contains 500 securities, it’s computationally heavier than a single-ticker back-test, so nailing down the above points up-front avoids wasted processing time. Let me know your preferences (or feel free to accept the default assumptions in each bullet), and I’ll launch the data-gathering and back-test run right away.